Commonwealth Equity Services, LLC Inovio Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.35 - $0.53 $325 - $492	-930 Reduced 3.9%	22,909 $12,000
Q3 2023 Oct 23, 2023	SELL	$0.38 - $0.58 $513 - $783	-1,350 Reduced 5.36%	23,839 $9,000
Q2 2023 Aug 10, 2023	SELL	$0.39 - $0.94 $302 - $728	-775 Reduced 2.98%	25,189 $11,000
Q1 2023 May 11, 2023	SELL	$0.79 - $1.91 $973 - $2,353	-1,232 Reduced 4.53%	25,964 $21,000
Q4 2022 Feb 07, 2023	SELL	$1.41 - $2.5 $564 - $1,000	-400 Reduced 1.45%	27,196 $42,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $166 - $279	100 Added 0.36%	27,596 $47,000
Q2 2022 Jul 19, 2022	SELL	$1.44 - $3.98 $17,712 - $48,954	-12,300 Reduced 30.91%	27,496 $47,000
Q1 2022 May 04, 2022	BUY	$2.97 - $5.2 $7,306 - $12,792	2,460 Added 6.59%	39,796 $142,000
Q4 2021 Jan 31, 2022	BUY	$4.99 - $7.46 $4,840 - $7,236	970 Added 2.67%	37,336 $186,000
Q3 2021 Oct 29, 2021	SELL	$7.16 - $9.69 $179 - $242	-25 Reduced 0.07%	36,366 $260,000
Q2 2021 Aug 11, 2021	SELL	$6.23 - $10.03 $11,238 - $18,094	-1,804 Reduced 4.72%	36,391 $337,000
Q1 2021 May 04, 2021	SELL	$8.81 - $16.96 $19,082 - $36,735	-2,166 Reduced 5.37%	38,195 $354,000
Q4 2020 Feb 11, 2021	BUY	$8.5 - $12.85 $8,041 - $12,156	946 Added 2.4%	40,361 $357,000
Q3 2020 Nov 05, 2020	BUY	$9.57 - $27.05 $114,237 - $322,895	11,937 Added 43.44%	39,415 $457,000
Q2 2020 Aug 12, 2020	BUY	$7.14 - $31.69 $50,237 - $222,970	7,036 Added 34.42%	27,478 $740,000
Q1 2020 May 11, 2020	BUY	$2.98 - $14.09 $60,917 - $288,027	20,442 New	20,442 $152,000
Q4 2019 Feb 05, 2020	SELL	$1.97 - $3.72 $51,227 - $96,734	-26,004 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$2.29 - $4.1 $10,151 - $18,175	-4,433 Reduced 14.56%	26,004 $76,000
Q1 2019 May 13, 2019	SELL	$3.34 - $5.1 $7,678 - $11,724	-2,299 Reduced 7.02%	30,437 $113,000
Q4 2018 Feb 11, 2019	BUY	$3.89 - $6.11 $7,885 - $12,384	2,027 Added 6.6%	32,736 $130,000
Q3 2018 Nov 06, 2018	BUY	$3.92 - $5.58 $50,756 - $72,249	12,948 Added 72.9%	30,709 $170,000
Q2 2018 Jul 31, 2018	BUY	$3.88 - $5.16 $2,308 - $3,070	595 Added 3.47%	17,761 $70,000
Q1 2018 May 14, 2018	SELL	$4.05 - $5.69 $4,864 - $6,833	-1,201 Reduced 6.54%	17,166 $80,000
Q4 2017 Feb 12, 2018	BUY	$4.13 - $6.68 $75,855 - $122,691	18,367	18,367 $76,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account